Syntec Bio

Based in the UK, Syntec Bio is a biotech firm focused on innovative solutions for biomass conversion into valuable industrial chemicals, enhancing sustainability in the chemical sector. Founded in 2021, Syntec Bio operates from its headquarters in London, UK. The company specializes in biotechnology aimed at transforming biomass into industrial chemicals, leveraging advanced fermentation techniques. In June 2025, Syntec Bio raised USD 1.

00 mn in Series A funding led by GreenEdge Capital, a strategic move to support their operational scaling and scientific endeavors. Syntec Bio specializes in developing a biomass conversion platform for industrial chemicals, focusing on utilizing fermentation technology. This platform aims to provide sustainable alternatives to traditional chemical processes, catering to industries looking for eco-friendly solutions. The company generates revenue through its innovative biomass conversion processes, aiming to facilitate the production of industrial chemicals.

Revenue streams are structured around the commercialization of their technology and partnerships with various industries seeking sustainable solutions. Following the recent Series A funding of USD 1. 00 mn secured in June 2025, Syntec Bio plans to build a pilot-scale fermentation facility and expand its scientific team. The funding will be allocated to developing their biomass conversion platform, with the goal of enhancing operational capabilities and exploring further commercial opportunities in the industrial chemicals market.